Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/127661
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sabaté Llobera, Aida | - |
dc.contributor.author | Cortés Romera, Montserrat | - |
dc.contributor.author | Mercadal, Santiago | - |
dc.contributor.author | Hernández Gañán, Javier | - |
dc.contributor.author | Pomares, Helena | - |
dc.contributor.author | González Barca, Eva | - |
dc.contributor.author | Gámez, Cristina | - |
dc.date.accessioned | 2019-01-28T13:03:34Z | - |
dc.date.available | 2019-01-28T13:03:34Z | - |
dc.date.issued | 2016-08-17 | - |
dc.identifier.issn | 1179-545X | - |
dc.identifier.uri | http://hdl.handle.net/2445/127661 | - |
dc.description.abstract | Computed tomography (CT) has been used as the reference imaging technique for the initial staging of diffuse large B-cell lymphoma until recent days, when the introduction of positron emission tomography (PET)/CT imaging as a hybrid technique has become of routine use. However, the performance of both examinations is still common. The aim of this work was to compare the findings between low-dose 2-deoxy-2-(F-18) fluoro-D-glucose (F-18-FDG) PET/CT and full-dose contrast-enhanced CT (ceCT) in 28 patients with localized diffuse large B-cell lymphoma according to PET/CT findings, in order to avoid the performance of ceCT. For each technique, a comparison in the number of nodal and extranodal involved regions was performed. PET/CT showed more lesions than ceCT in both nodal (41 vs. 36) and extranodal localizations (16 vs. 15). Disease staging according to both techniques was concordant in 22 patients (79%) and discordant in 6 patients (21%), changing treatment management in 3 patients (11%). PET/CT determined a better staging and therapeutic approach, making the performance of an additional ceCT unnecessary. | - |
dc.format.extent | 4 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Libertas Academica Limited | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.4137/CMBD.S38468 | - |
dc.relation.ispartof | Clinical Medicine Insights: Blood Disorders, 2016, vol. 9, p. 29-32 | - |
dc.relation.uri | https://doi.org/10.4137/CMBD.S38468 | - |
dc.rights | cc-by-nc (c) Sabaté Llobera et al., 2016 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/es | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Limfomes | - |
dc.subject.classification | Tomografia | - |
dc.subject.other | Lymphomas | - |
dc.subject.other | Tomography | - |
dc.title | Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 679876 | - |
dc.date.updated | 2019-01-28T13:03:35Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 27559300 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
679876.pdf | 1.05 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License